Alternatively, CD8+ cells could act by interfering with de novo infection or the release of new virions through soluble antiviral factors, including the CCR5-binding proteins MIP-1α, MIP-1β, RANTES, the cellular anti-HIV factor (CAF), α-defensins, and other factors35–37. Here, CD8A is linked to infection.